Brand Name Prescription Drugs – Antitrust Class Action Settlement
Our founding partner is recognized for pioneering the modern antitrust class action, leading to the recovery of billions of dollars for our clients and the classes we represent. Since our founding in 1970, Berger Montague has litigated many of the most significant civil antitrust cases alleging price fixing and monopoly abuse.
Our founding partner is recognized for pioneering the modern antitrust class action, leading to the recovery of billions of dollars for our clients and the classes we represent.
Since our founding in 1970, Berger Montague has litigated many of the most significant civil antitrust cases alleging price fixing and monopoly abuse, including, for example, Bogosian v. Gulf Oil Corp., In re Corrugated Container Antitrust Litigation, In re Currency Conversion Fee Antitrust Litigation, and In re Infant Formula Antitrust Litigation.
Berger Montague has also played a principal role in obtaining over one billion dollars in settlements from drug companies alleged to have impeded the entry of generics and artificially inflated drug prices. As a result of our successes and the skill, reputation and experience of our Firm’s antitrust lawyers, Berger Montague is routinely appointed by federal courts to serve in leadership roles in complex antitrust class action cases.
For example, Berger Montague has been appointed by federal courts as lead or co-lead counsel in some of the most significant and complex antitrust cases on behalf of businesses and consumers, including:
The Firm and its lawyers are regularly recognized by Chambers & Partners, The Legal 500, Martindale-Hubbell, America’s Best Lawyers, Lawdragon.com, and The National Law Journal for outstanding work in antitrust litigation. Chambers & Partners notes with reference to the antitrust practice that the firm is “the top choice for plaintiff antitrust representation, particularly in complex class actions” and that it “stand[s] out by virtue of its first-class trial skills.”
We invite you to learn more about our Antitrust Group. Berger Montague welcomes referrals from other law firms and attorneys. For more information or to schedule a confidential discussion about a potential case, please fill out the contact form on the right, email us at [email protected], or contact an Antitrust Group shareholder. We are available to evaluate potential antitrust cases without charge.
Berger Montague serves on the Plaintiffs’ Steering Committee for a proposed class of generic drug purchasers in price-fixing and market allocation litigation brought against many of the generic drug...join the case